Type III hypersensitivity reaction with immune complex deposition in 2 critically ill dogs administered human serum albumin

Journal of Veterinary Emergency and Critical Care

Volumn 23, Issue 6, 2013, Pages 598-604

  Powell, Cassandra ^a   Thompson, Lisa ^b   Murtaugh, Robert J ^a  

^a VCA All Care Animal Referral Center   (United States)

^b Center for Veterinary Specialty Care   (United States)

Author keywords

Canine; Complication; Drug reaction; Immunohistochemistry; Vasculitis

Indexed keywords

CANIS FAMILIARIS; ORYCTOLAGUS CUNICULUS;

SERUM ALBUMIN;

ANIMAL; ANIMAL DISEASE; ARTICLE; CANINE; CASE REPORT; CHEMICALLY INDUCED DISORDER; COMPLICATION; CRITICAL ILLNESS; DOG; DOG DISEASE; DRUG HYPERSENSITIVITY; DRUG-REACTION; FEMALE; HUMAN; IMMUNE COMPLEX DISEASE; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; MALE; PATHOLOGY; VASCULITIS;

CANINE; COMPLICATION; DRUG-REACTION; IMMUNOHISTOCHEMISTRY; VASCULITIS;

ANIMALS; CRITICAL ILLNESS; DOG DISEASES; DOGS; DRUG HYPERSENSITIVITY; FEMALE; HUMANS; IMMUNE COMPLEX DISEASES; MALE; SERUM ALBUMIN; VASCULITIS;

EID: 84889088936     PISSN: 14793261     EISSN: 14764431     Source Type: Journal    
DOI: 10.1111/vec.12085     Document Type: Article

References (22)

1. Mathews KA, Barry M. The use of 25% human serum albumin: outcome and efficacy in raising serum albumin and systemic blood pressure in critically ill dogs and cats. J Vet Emergency and Crit Care 2005; 15:110-118.
2. Trow AT, Rozaanski EA, deLaforcade AM, et al. Evaluation of use of human albumin in critically ill dogs: 73 cases (2003-2006). J Am Vet Med Assoc 2008; 233(4):607-612.
3. Delaney AP, McCaffrey DA, Finfer S. The role of albumin as a resuscitation fluid for patients with sepsis: a systemic review and meta-analysis. Crit Care Med 2011; 39(2):386-391.
4. Cochrane Injuries Group Albumin Reviewers. Human albumin administration in critically ill patients: systematic review of randomized controlled trials. BMJ 1998; 317(7153):235-240.
5. Mazzaferro EM, Rudloff E, Kirby R. The role of albumin replacement in the critically ill veterinary patient. J Vet Emergency and Crit Care 2002; 12(2):113-124.
6. Center S. Fluid, electrolyte, and acid-base disturbances in liver disease. In: DiBartola SP. ed. Fluid, Electrolyte and Acid-Base Disorders in Small Animal Practice, 3rd ed. Philadelphia: Elselvier Inc.; 2006, pp. 437-477.
7. Cohn LA, Kerl, ME, Lenox CA, et al. Response of healthy dogs to infusions of human serum albumin. Am J Vet Research 2007; 68(6):657-663.
8. Francis HA, Martin LG, Haldorson GJ, et al. Adverse reactions suggestive of type III hypersensitivity in six healthy dogs given human albumin. J Am Vet Med Assoc 2007; 230(6):873-879.
9. Martin LM, Luther TY, Alperin DC, et al. Serum antibodies against human albumin in critically ill and healthy dogs. J Am Vet Med Assoc 2008; 232(7):1004-1008.
10. Tizard IR. Immune complexes and type III hypersensitivity. In: Tizard IR. ed. Veterinary Immunology, 6th ed. Philadelphia: W.B Saunders Company; 2000, pp. 332-341.
11. Kanji S, Chant C. Allergic and hypersensitivity reactions in the intensive care unit. Crit Care Med 2010; 38(6):S162-S168.
12. Churg, A. Pathologic features of vasculitis. In: Ball GV, Bridges SL. eds. Vasculitis, 2nd ed. New York: Oxford University Press; 2008, pp. 67-88.
13. Grunwald MH, Avinoach I, Amichai B, et al. Leukocytoclastic vasculitis-correlation between different histologic stages and direct immunofluorescence results. Int J Dermatol 1997; 36:349-352.
14. Bert JL, Mathieson JM, Pearce RH. The exclusion of albumin by dermal collagenous fibres within human dermis. Biochem J 1982; 201:395-403.
15. Kerl ME, Cohn LA, Throop JL. Albumin in health and disease: causes and treatment of hypoalbuminemia. Compend Contin Educ Pract Vet 2004; 26(12):940-949.
16. Von Hoegen I, Waller C. Safety of human albumin based on spontaneously reported serious adverse events. Crit Care Med 2001; 29(5):994-996.
17. Vincent JL, Dubois MJ, Navickis RJ, et al. Hypoalbuminemia in acute illness: is there rationale for intervention? A meta-analysis of cohort studies and controlled trials. Ann Surg 2003; 237(3):319-334.
18. Vincent JL, Navickis RJ, Wilkes MM. Morbidity in hospitalized patients receiving human albumin: a meta-analysis of randomized, controlled trials. Crit Care Med 2004; 32(10):2029-2038.
19. The SAFE Study Investigators. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004; 350(22):2247-2256.
20. The SAFE Study Investigators, Finfer S, Bellomo R, et al. Saline or albumin for fluid resuscitation in patients with traumatic brain injury. N Engl J Med 2007; 357(9):874-884.
21. Sort P, Navasa M, Arroyo V. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 1999; 341(6):403-409.
22. Vigano F, Perissinotto L, Bosco VR. Administration of 5% human serum albumin in critically ill small animal patients with hypoalbuminemia: 418 dogs and 170 cats (1994-2008). J Vet Emergency and Crit Care 2010; 20(2):237-243.